Figure S1. The portion of chronic LFTs abnormalities and NAFLD patients according to Non-HDL/ HDL levels tertiles. The cut of values of Non-HDL / HDL ratio were =2.96.#P value compared with Tertile 1,#P < 0.05. (TIF 1338 kb
Table S1. List of antibodies used in fluorescent immunohistochemistry. (DOC 36 kb
Figure S1. Chromatogram of fatty acids standards. Figure S2 (a). Chromatogram of serum total fatty a...
Table S2. Association of serum SHBG levels with metabolic risk factors using multiple linear regress...
Figure S2. The portion of NAFLD patients according to Non-HDL/ HDL levels tertiles. The cut of value...
Table S1. Relative Risk of some factors in normal and NAFLD groups. Table S2. Variable scoring list ...
Table S1. Stratified analysis of NAFLD and platelet count in different subgroup. (DOCX 27 kb
Abstract Background Excessive lipid depositing in liver cells could induce pathophysiological develo...
Odds ratios for NAFLD in different quartiles of TyG index or ALT in ALT <40 and âĽ40 U/L groups. Ta...
Table S1. Characteristics of NHANES III Participants Aged 60 to 74 year, by NAFLD status, U.S. 1988–...
Electronic Supplementary Material: Figure S1. Histogram of MRI-derived liver fat content (%) values....
Additional file 2. Table S1. The results of univariate analysis. Table S2. The characteristics of pa...
Table S1. Prevalence of comorbidities in overweight (Nâ=â14) and obese (12) NAFLD patients. In o...
Figure S1. Diagnostic odds ratio (DOR) of CAP for steatosis in suspected NAFLD patients. Figure S2. ...
Is presenting results analyzed using a nonimputed data set. *Adjusted for demographics, health behav...
Additional file 1. Figure S1. Prevalence of NAFLD according to the quintiles of SUA/Scr ratio
Table S1. List of antibodies used in fluorescent immunohistochemistry. (DOC 36 kb
Figure S1. Chromatogram of fatty acids standards. Figure S2 (a). Chromatogram of serum total fatty a...
Table S2. Association of serum SHBG levels with metabolic risk factors using multiple linear regress...
Figure S2. The portion of NAFLD patients according to Non-HDL/ HDL levels tertiles. The cut of value...
Table S1. Relative Risk of some factors in normal and NAFLD groups. Table S2. Variable scoring list ...
Table S1. Stratified analysis of NAFLD and platelet count in different subgroup. (DOCX 27 kb
Abstract Background Excessive lipid depositing in liver cells could induce pathophysiological develo...
Odds ratios for NAFLD in different quartiles of TyG index or ALT in ALT <40 and âĽ40 U/L groups. Ta...
Table S1. Characteristics of NHANES III Participants Aged 60 to 74 year, by NAFLD status, U.S. 1988–...
Electronic Supplementary Material: Figure S1. Histogram of MRI-derived liver fat content (%) values....
Additional file 2. Table S1. The results of univariate analysis. Table S2. The characteristics of pa...
Table S1. Prevalence of comorbidities in overweight (Nâ=â14) and obese (12) NAFLD patients. In o...
Figure S1. Diagnostic odds ratio (DOR) of CAP for steatosis in suspected NAFLD patients. Figure S2. ...
Is presenting results analyzed using a nonimputed data set. *Adjusted for demographics, health behav...
Additional file 1. Figure S1. Prevalence of NAFLD according to the quintiles of SUA/Scr ratio
Table S1. List of antibodies used in fluorescent immunohistochemistry. (DOC 36 kb
Figure S1. Chromatogram of fatty acids standards. Figure S2 (a). Chromatogram of serum total fatty a...
Table S2. Association of serum SHBG levels with metabolic risk factors using multiple linear regress...